Why U.S. first may be the new medical device development strategy

[Image from Unsplash]

Increased regulatory hurdles in Europe and China could mean more medical device development focusing on the U.S. market first.

That seemed to be a major takeaway from panels on regulation and reimbursement at Healthegy’s Medtech Conference, held last week in Minneapolis.

“We’re actually going to be doing more early clinical work with the FDA,” said Stacey Pugh, vice president and general manager of neurovascular at Medtronic.

Get the full story on our sister site, Medical Design & Outsourcing.

The post Why U.S. first may be the new medical device development strategy appeared first on MassDevice.

from MassDevice http://ift.tt/2qUM7Fs